These two Food and Drug Administration-approved drugs for cancer treatment may hold the key to reversing Alzheimer's disease ...

The European Medicines Agency (EMA) has granted limited approval to Eli Lilly’s (LLY) new Alzheimer’s drug Kisunla, reversing ...

CIHR Institute of Aging’s scientific director announces new Canadian funding and discusses where the research is headed ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

While more research is needed, including human trials, the results are promising. The drug SW033291 could lead to a new type ...

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

Frontotemporal Dementia is complex in how it literally changes the essence of a person. Public figures such as Bruce Willis; ...